Delivery Order SPE2DB24D8001-SPE2DB25FKYVL

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $5,267.34. It is an unrestricted, non-set-aside contract that allows Dakota Drug, Inc. to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $4,126.76. It is a firm fixed price contract for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract does not have a...
This is a delivery order contract (SPE2DB24D8002/SPE2DB25FJNCT) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $10,364.55 and a completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYWG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, which is a Delivery Order under the DLA Troop Support Medical's ECAT Generation V Program, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, including prescription medications, medical devices, vaccines, and other healthcare-related items. The contract...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The award, valued at $3,457.84, is a delivery order under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price of $1,928.41 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract has a ceiling value of $8,761.45 and runs through June 11, 2025. It is an unrestricted, non-set-aside contract. Dakota Drug, Inc. holds...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract award, identified as SPE2DB24D8001, is a $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of medical items to support U.S....
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZHD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract is an Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, with a ceiling value of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the provision of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has a ceiling value of $24,655.63 and is a firm-fixed-price delivery order. It is part of the DLA Troop Support Medical's ECAT Generation V Program, a...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKYVL
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $11,580.84. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. It is a firm fixed-price, unrestricted contract with a performance period through November 14, 2024. Dakota Drug, Inc. also holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00, which enables the company to efficiently deliver a comprehensive range of critical medical items to various defense healthcare facilities.

Generated 2/12/25, 9:26 AM